134 related articles for article (PubMed ID: 27539844)
21. Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes.
Mc Larney BE; Zhang Q; Pratt EC; Skubal M; Isaac E; Hsu HT; Ogirala A; Grimm J
J Nucl Med; 2023 Jan; 64(1):177-182. PubMed ID: 35738902
[TBL] [Abstract][Full Text] [Related]
22. In situ lymphoma imaging in a spontaneous mouse model using the Cerenkov Luminescence of F-18 and Ga-67 isotopes.
Ritter Z; Zámbó K; Balogh P; Szöllősi D; Jia X; Balázs Á; Taba G; Dezső D; Horváth I; Alizadeh H; Tuch D; Vyas K; Hegedűs N; Kovács T; Szigeti K; Máthé D; Schmidt E
Sci Rep; 2021 Dec; 11(1):24002. PubMed ID: 34907289
[TBL] [Abstract][Full Text] [Related]
23. Site-specific antibody fragment conjugates for targeted imaging.
Maloney R; Buuh ZY; Zhao Y; Wang RE
Methods Enzymol; 2020; 638():295-320. PubMed ID: 32416919
[TBL] [Abstract][Full Text] [Related]
24. Removal of random-valued impulse noise from Cerenkov luminescence images.
Chen D; Zhu S; Huang Y; Liang J; Chen X
Med Biol Eng Comput; 2020 Jan; 58(1):131-141. PubMed ID: 31754979
[TBL] [Abstract][Full Text] [Related]
25. Design of Cerenkov Radiation-Assisted Photoactivation of TiO
Kavadiya S; Biswas P
J Nucl Med; 2019 May; 60(5):702-709. PubMed ID: 30291195
[TBL] [Abstract][Full Text] [Related]
26. Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection.
Carter LM; Poty S; Sharma SK; Lewis JS
J Labelled Comp Radiopharm; 2018 Jul; 61(9):611-635. PubMed ID: 29412489
[TBL] [Abstract][Full Text] [Related]
27. Cerenkov luminescence imaging: physics principles and potential applications in biomedical sciences.
Ciarrocchi E; Belcari N
EJNMMI Phys; 2017 Dec; 4(1):14. PubMed ID: 28283990
[TBL] [Abstract][Full Text] [Related]
28. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies.
Liu S; Li D; Park R; Liu R; Xia Z; Guo J; Krasnoperov V; Gill PS; Li Z; Shan H; Conti PS
J Nucl Med; 2013 Jul; 54(7):1094-100. PubMed ID: 23667241
[TBL] [Abstract][Full Text] [Related]
29. Cerenkov imaging.
Das S; Thorek DL; Grimm J
Adv Cancer Res; 2014; 124():213-34. PubMed ID: 25287690
[TBL] [Abstract][Full Text] [Related]
30. Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.
D'Souza JW; Hensley H; Doss M; Beigarten C; Torgov M; Olafsen T; Yu JQ; Robinson MK
J Nucl Med; 2017 Jan; 58(1):175-180. PubMed ID: 27539844
[TBL] [Abstract][Full Text] [Related]
31. Comparative immuno-Cerenkov luminescence and -PET imaging enables detection of PSMA
Maier FC; Wild AM; Kirchen N; Holm F; Fuchs K; Schwenck J; Maurer A; Wiehr S
Appl Radiat Isot; 2019 Jan; 143():149-155. PubMed ID: 30445280
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives.
Viola-Villegas NT; Sevak KK; Carlin SD; Doran MG; Evans HW; Bartlett DW; Wu AM; Lewis JS
Mol Pharm; 2014 Nov; 11(11):3965-73. PubMed ID: 24779727
[TBL] [Abstract][Full Text] [Related]
33. Cerenkov luminescence imaging of medical isotopes.
Ruggiero A; Holland JP; Lewis JS; Grimm J
J Nucl Med; 2010 Jul; 51(7):1123-30. PubMed ID: 20554722
[TBL] [Abstract][Full Text] [Related]
34. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.
Elsässer-Beile U; Reischl G; Wiehr S; Bühler P; Wolf P; Alt K; Shively J; Judenhofer MS; Machulla HJ; Pichler BJ
J Nucl Med; 2009 Apr; 50(4):606-11. PubMed ID: 19289418
[TBL] [Abstract][Full Text] [Related]
35. Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.
Timmermand OV; Tran TA; Strand SE; Axelsson J
J Nucl Med; 2015 Mar; 56(3):444-9. PubMed ID: 25655628
[TBL] [Abstract][Full Text] [Related]
36. Review of biomedical Čerenkov luminescence imaging applications.
Tanha K; Pashazadeh AM; Pogue BW
Biomed Opt Express; 2015 Aug; 6(8):3053-65. PubMed ID: 26309766
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
